First BTK inhibitor to show favourable trend in overall survival vs. standard-of-care chemoimmunotherapy in this setting
Shanghai Roche Pharmaceuticals and Shanghai KeChow Pharma, entered into a cooperation agreement to improve market access of Zelboraf in China.
The company said the safety profile remained consistent with earlier studies and was considered manageable
Study of 78,000 diagnostic investigations by Mahajan Imaging identifies over 13,000 abnormal or critical findings, highlighting silent health risks among working-age men
An exploratory overall survival signal also leaned in favor of the combination, though the companies noted the result remains preliminary
AAV vectors are widely used in gene therapy for their strong therapeutic potential
Nationwide preventive health initiative aims to make cardiovascular screening at age 30 a standard healthcare milestone
The pharmaceutical giant reported $14.5 billion in revenue, up 5% year-over-year, and reaffirmed its full-year outlook
Originally established in Punjab, the Vasculitis Society of India is now expanding its footprint nationwide
Medical experts point to a growing body of research linking energy drinks to liver injury
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
